Xiduo Pharmaceuticals announced that the company recently received the "Acceptance Notice" for the registration and listing of domestically produced pharmaceuticals for glucosamine sulfate capsules issued by the State Drug Administration.
西点药业：收到药品注册受理通知书
Xiduo Pharmaceuticals: Received Pharmaceutical Registration Acceptance Notification
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.